Page last updated: 2024-11-05

1,12-dodecamethylenediamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,12-dodecamethylenediamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dodecane-1,12-diamine : An alkane-alpha,omega-diamine that is dodecane substituted by amino groups at positions 1 and 12. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID17727
CHEMBL ID69590
CHEBI ID49385
SCHEMBL ID27441
MeSH IDM0066371

Synonyms (48)

Synonym
bdbm50147574
nsc 55050
einecs 220-489-6
brn 1742765
1,12'-dodecylenediamine
nsc 59861
1,12'-dodecamethylenediamine
dodecyldiamine
1,12-dodecamethylenediamine
nsc55050
2783-17-7
1,12-diamindodecane
1,12-diaminododecane
nsc-59861
1,12-dodecylenediamine
dodecamethylenediamine
nsc-55050
nsc59861
1,12-dodecanediamine
1,12-diaminododecane, 98%
dodecane-1,12-diamine
D0091
chebi:49385 ,
CHEMBL69590 ,
unii-j3lm80w9nt
4-04-00-01376 (beilstein handbook reference)
j3lm80w9nt ,
A819207
FT-0606044
AKOS015894529
SCHEMBL27441
1,12diaminododecane
1,12 diaminododecane
1,12-diamino dodecane
dodecamethylene diamine
DTXSID2044636
Q-200047
1,12-n-dodecanediamine
1,12-diamino-n-dodecane
dodecylenediamine
STL492207
mfcd00008155
F19630
n12n
1,12-dodecane-diamine
Q27121625
BBL036612
CS-W015599
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkane-alpha,omega-diamineA primary diamine that is ethane or a higher alkane in which a hydrogen of each of the terminal methyl groups has been replaced by an amino group. H2NCH2(CH2)nCH2NH2, where n = 0, 1, 2, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)IC50 (µMol)250.74000.00071.600310.0000AID1235076; AID1235077; AID1235079; AID287173; AID287175
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)IC50 (µMol)250.74000.00071.630610.0000AID1235076; AID1235077; AID1235079; AID287173; AID287175
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)IC50 (µMol)250.74000.00061.525710.0000AID1235076; AID1235077; AID1235079; AID287173; AID287175
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)IC50 (µMol)250.74000.00071.747210.0000AID1235076; AID1235077; AID1235079; AID287173; AID287175
Dynamin-1Homo sapiens (human)IC50 (µMol)39.65003.15004.17335.0000AID63727
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)IC50 (µMol)250.74000.00071.741110.0000AID1235076; AID1235077; AID1235079; AID287173; AID287175
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)IC50 (µMol)250.74000.00071.741110.0000AID1235076; AID1235077; AID1235079; AID287173; AID287175
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)IC50 (µMol)250.74000.00071.741110.0000AID1235076; AID1235077; AID1235079; AID287173; AID287175
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
endocytosisDynamin-1Homo sapiens (human)
receptor-mediated endocytosisDynamin-1Homo sapiens (human)
endosome organizationDynamin-1Homo sapiens (human)
modulation of chemical synaptic transmissionDynamin-1Homo sapiens (human)
protein homooligomerizationDynamin-1Homo sapiens (human)
protein homotetramerizationDynamin-1Homo sapiens (human)
regulation of vesicle sizeDynamin-1Homo sapiens (human)
clathrin coat assembly involved in endocytosisDynamin-1Homo sapiens (human)
vesicle scissionDynamin-1Homo sapiens (human)
receptor internalizationDynamin-1Homo sapiens (human)
synaptic vesicle budding from presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
RNA bindingDynamin-1Homo sapiens (human)
GTPase activityDynamin-1Homo sapiens (human)
protein bindingDynamin-1Homo sapiens (human)
GTP bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-4,5-bisphosphate bindingDynamin-1Homo sapiens (human)
phosphatidylinositol-3,4,5-trisphosphate bindingDynamin-1Homo sapiens (human)
GDP bindingDynamin-1Homo sapiens (human)
protein kinase bindingDynamin-1Homo sapiens (human)
identical protein bindingDynamin-1Homo sapiens (human)
protein homodimerization activityDynamin-1Homo sapiens (human)
microtubule bindingDynamin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
photoreceptor inner segmentDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
clathrin-coated pitDynamin-1Homo sapiens (human)
endocytic vesicleDynamin-1Homo sapiens (human)
chromaffin granuleDynamin-1Homo sapiens (human)
cell projectionDynamin-1Homo sapiens (human)
extracellular exosomeDynamin-1Homo sapiens (human)
photoreceptor ribbon synapseDynamin-1Homo sapiens (human)
presynapseDynamin-1Homo sapiens (human)
presynaptic endocytic zone membraneDynamin-1Homo sapiens (human)
glutamatergic synapseDynamin-1Homo sapiens (human)
membrane coatDynamin-1Homo sapiens (human)
plasma membraneDynamin-1Homo sapiens (human)
synapseDynamin-1Homo sapiens (human)
microtubuleDynamin-1Homo sapiens (human)
cytoplasmDynamin-1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1247114Ratio of IC50 for NMDA receptor in Wistar rat brain membranes in presence of 1.3 mM Mg2+ to IC50 for NMDA receptor in Wistar rat brain membranes in absence of 1.3 mM Mg2+2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID1247110Ratio of IC50 for NMDA receptor in Wistar rat brain membranes in presence of H+ at pH 6.4 to 8.2 to IC50 for NMDA receptor in Wistar rat brain membranes in absence of H+ at pH 6.4 to 8.22015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID1247107Displacement of [3H]MK-801 from NMDA receptor in Wistar rat brain membranes by scintillation counting analysis2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID1247109Ratio of IC50 for NMDA receptor in Wistar rat brain membranes in presence of 10 to 50 mM Tris to IC50 for NMDA receptor in Wistar rat brain membranes in absence of 10 to 50 mM Tris2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID1247112Ratio of IC50 for NMDA receptor in Wistar rat brain membranes in presence of 50 mM K+ to IC50 for NMDA receptor in Wistar rat brain membranes in absence of 50 mM K+2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID1247108Ratio of IC50 for NMDA receptor in Wistar rat brain membranes in presence of 30 uM spermine to IC50 for NMDA receptor in Wistar rat brain membranes in absence of 30 uM spermine2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID1247113Ratio of IC50 for NMDA receptor in Wistar rat brain membranes in presence of 20 mM NH4+ to IC50 for NMDA receptor in Wistar rat brain membranes in absence of 20 mM NH4+2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID63727Concentration required against dynamin-1 GTPase activity of sheep brain.2004Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
Long chain amines and long chain ammonium salts as novel inhibitors of dynamin GTPase activity.
AID448532Cytotoxicity against Mycobacterium bovis Bacillus Calmette-Guerin infected mouse J774 macrophage assessed as cell viability at 1 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID287173Displacement of [3H]MK-801 from rat brain NMDA receptor2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
New polyamine-sensitive inhibitors of the NMDA receptor: syntheses and pharmacological evaluation.
AID448530Cytotoxicity against mouse J774 macrophage assessed as cell viability at 10 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID1235077Displacement of [3H]-MK-801 from rat cortical membranes NMDA receptor by beta counting analysis in presence of 30 uM spermine2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.
AID448380Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as minimum inhibitory concentration after 24 hrs by micro plate Alamar blue assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID1235076Displacement of [3H]-MK-801 from rat cortical membranes NMDA receptor by beta counting analysis in absence of spermine2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.
AID448381Cytotoxicity against mouse J774 macrophage assessed as cell viability at 1 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID49963Minimum inhibitory concentration against Candida glabrata2002Bioorganic & medicinal chemistry letters, Aug-19, Volume: 12, Issue:16
Antifungal activity of bifunctional sphingolipids. Intramolecular synergism within long-chain alpha,omega-bis-aminoalcohols.
AID1235078Ratio of IC50 for displacement of [3H]-MK-801 from rat cortical membranes NMDA receptor in presence of 30 uM spermine to IC50 for displacement of [3H]-MK-801 from rat cortical membranes NMDA receptor in absence of 30 spermine2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.
AID1247111Ratio of IC50 for NMDA receptor in Wistar rat brain membranes in presence of 3 to 50 mM Na+ to IC50 for NMDA receptor in Wistar rat brain membranes in absence of 3 to 50 mM Na+2015Bioorganic & medicinal chemistry letters, Oct-01, Volume: 25, Issue:19
Differential influence of 7 cations on 16 non-competitive NMDA receptor blockers.
AID448531Cytotoxicity against mouse J774 macrophage assessed as cell viability at 100 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID287175Displacement of [3H]MK801 from rat brain NMDA receptor in presence of 30 uM spermine2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
New polyamine-sensitive inhibitors of the NMDA receptor: syntheses and pharmacological evaluation.
AID448534Cytotoxicity against Mycobacterium bovis Bacillus Calmette-Guerin infected mouse J774 macrophage assessed as cell viability at 100 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
AID1235079Displacement of [3H]-ifenprodil from rat cortical membranes NMDA receptor by beta counting analysis in absence of spermine2015Bioorganic & medicinal chemistry, Aug-01, Volume: 23, Issue:15
Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors.
AID448533Cytotoxicity against Mycobacterium bovis Bacillus Calmette-Guerin infected mouse J774 macrophage assessed as cell viability at 10 ug/mL after 48 hrs by MTT assay2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (4.17)18.7374
1990's3 (12.50)18.2507
2000's12 (50.00)29.6817
2010's8 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.85 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]